Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126526431 | 12652643 | 1 | I | 20160707 | 20160808 | 20160815 | 20160815 | EXP | GB-MHRA-MIDB-4630A4D7-DEB2-4244-9E5B-9DC18BE647B2 | GB-SA-2016SA145954 | AVENTIS | 73.00 | YR | E | M | Y | 0.00000 | 20160815 | PH | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126526431 | 12652643 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | Y | UNK | 18538 | 2.5 | MG | QD | ||||||
126526431 | 12652643 | 2 | C | IRBESARTAN. | IRBESARTAN | 1 | 0 | 150 | MG | QD | |||||||||
126526431 | 12652643 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 125MCG /150MCG ALTERNATIVE DAYS | 0 | |||||||||||
126526431 | 12652643 | 4 | C | MOXONIDINE | MOXONIDINE | 1 | AT NIGHT | 0 | 200 | UG | QD | ||||||||
126526431 | 12652643 | 5 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | 20 | MG | QD |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126526431 | 12652643 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126526431 | 12652643 | Acute kidney injury | |
126526431 | 12652643 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126526431 | 12652643 | 1 | 20160707 | 0 |